Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.IsoAid, a provider of brachytherapy products, and Amerinet, a healthcare group purchasing organization, have announced that IsoAid has been awarded a three-year brachytherapy contract to provide Amerinet members with a complete line of brachytherapy products used primarily in the treatment of prostate cancer.
Subscribe to our email newsletter
The agreement will begin on October 1, 2008 and run for a three-year term. The agreement is said to offer Amerinet’s membership competitive market pricing, and access to IsoAid’s Advantage I-125 and Advantage Pd-103 seeds and related brachytherapy products.